CME Merger Talks Raise Fee Concern That May Stymie Deal

CME Group Inc.’s overtures toward Deutsche Boerse AG are likely to raise the same concern among customers about higher fees that helped scuttle last year’s deal with NYSE Euronext.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.